Vesicare is going generic in mid-2019 at the earliest. Myrbetriq will go generic in late-2022, or even later pending some court decisions. The big wildcard for the Primary Care sales force is fezolinetant (post-menopausal hot flashes), which would be prescribed by both PCPs and ObGyns. It could be huge (i.e., bigger than Xtandi). Stay tuned...
here is what’s really happening Vesicare is going generic Q4 2018 Myrbetriq will go generic in late-2019, or even earlyer pending some court decisions. United, Aetna, CVS is not covering The big wildcard for the Primary Care sales force is fezolinetant for dryholed ol skank kunts (post-menopausal hot flashes), which will never be prescribed by both PCPs or ObGyns. It Is nothing but a me three and no different than generic, in short not covered. Nothing to Stay tuned for the expulsion of field based employees. And may I add well over due.
You really want to sell Myrbetriq for 4 more years?? My God, I can't find anything new to talk about now!
